---
DrugClass: "[[Skeletal Muscle, Bone, and Joint Disorder Drugs]]"
SubClass: "[[Disease-modifying antirheumatic drugs (DMARDs)]]"
DrugClassContra: "[[Disease-modifying antirheumatic drugs (DMARDs)#Contraindications]]"
DrugClassAdverse: "[[Disease-modifying antirheumatic drugs (DMARDs)#Adverse Reactions]]"
SecondaryDrugClass: "[[Traditional Chemotherapy]]"
SecondarySubClass: "[[Cell cycle– specific agents]]"
BrandName: Trexall, Xatmep, RediTrex
Chapter: "29"
KindleLinkChap: "[Chapter 29](kindle://book?action=open&asin=B09FRF11YJ&location=15248)"
KindleLink: 
tags:
  - Drug
  - Pharmacology
Course: Pharmacology
ChemLink: https://pubchem.ncbi.nlm.nih.gov/#query=
SecondaryAdverse: "[[Traditional Chemotherapy#Side/Adverse Effects]]"
SecondaryContra: "[[Traditional Chemotherapy#Contraindications]]"
SubCat: Antimetabolites
---
```smiles
CN(CC1=CN=C2C(=N1)C(=NC(=N2)N)N)C3=CC=C(C=C3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
```

### Brand name
`=this.BrandName`

### Generic name
`= this.file.name`

### Drug class 
`= this.DrugClass`
	`= this.DrugClass.KindleLinkChap`
`= this.SecondaryDrugClass`
	`= this.SecondaryDrugClass.KindleLinkChap`

### Dosage & Usage
RA, psoriatic arthritis (PA), cancer chemotherapy 
7.5– 20.0 mg orally once weekly
[[Leukemia]]/lymphomas; [[acute lymphoblastic leukemia]], non-Hodgkin [[Lymphoma]] 
Solid tumors: breast, head/neck, choriocarcinomas, osteosarcomas 
Nonmalignant: [[mycosis fungoides]], severe psoriasis, rheumatoid arthritis 
Unlabeled use: multiple sclerosis, [[Inflammatory Bowel Disease]] 

### Contraindications
See `= this.DrugClassContra`
See `= this.SecondaryContra`

### Mechanisms of Action

### Side/Adverse Effects
See `= this.DrugClassAdverse`
See `= this.SecondaryAdverse`
Nausea, [[stomatitis]], alopecia
Immediate: nausea, vomiting (high dose) 
During therapy cycles: anemia, [[leukopenia]], [[thrombocytopenia]], [[Stomatitis]], diarrhea, renal damage 
Long term: [[Hepatotoxicity]] 

### Interactions

`= this.ChemLink+this.file.name`

